Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 0 | -7,400 | 0 | 0 |
| Depreciation Amortization | 0 | 0 | 12,480 | 0 | 0 |
| Other Working Capital | 0 | 0 | 7,630 | 0 | 0 |
| Other Operating Activity | 0 | 0 | -4,140 | -13,910 | 0 |
| Operating Cash Flow | $0 | $0 | $8,570 | $-13,910 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -23,590 | -23,390 | 0 |
| Net Acquisitions | 0 | 0 | 1,910 | 0 | 0 |
| Other Investing Activity | 0 | 0 | -2,710 | -2,800 | 0 |
| Investing Cash Flow | $0 | $0 | $-24,390 | $-26,190 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 14,180 | 50,860 | 0 |
| Financing Cash Flow | $0 | $0 | $14,180 | $50,860 | $0 |
| Beginning Cash Position | 0 | 0 | 40,660 | 53,290 | 0 |
| End Cash Position | 0 | 0 | 39,020 | 64,050 | 0 |
| Net Cash Flow | $0 | $0 | $-1,630 | $10,760 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 0 | 8,570 | -13,910 | 0 |
| Free Cash Flow | 0 | 0 | 8,570 | -13,910 | 0 |